Navigation Links
PA Governor Rendell Signs 3 Bills Into Law
Date:5/13/2008

HARRISBURG, Pa., May 13 /PRNewswire-USNewswire/ -- Governor Edward G. Rendell today signed three bills into law:

Senate Bill 636 establishes a voluntary cancer drug repository program that allows pharmacies, under the supervision of the State Board of Pharmacy, to redispense unused cancer drugs to cancer patients.

Under the program, drugs may be returned to an approved pharmacy to be redispensed, provided that they are in their original packaging and the drug expires no sooner than six months after the date the cancer drug was restocked. Drugs dispensed under a state medical assistance program may be accepted and dispensed.

Senate Bill 1017 amends the Phosphate Detergent Act of 1989 to eliminate the current exception to phosphate standards for dishwashing detergent used by households.

The change means the amount of phosphorous in the waste stream will be reduced by 24 percent and municipal treatment facilities across the state will save $7 million a year.

The change takes effect July 1, 2010.

Senate Bill 1278 amends portions of Title 23 (Domestic Relations) to further provide for child medical support, review of support orders, annual fees, and assignment of support.

The Rendell administration is committed to creating a first-rate public education system, protecting our most vulnerable citizens and continuing economic investment to support our communities and businesses. To find out more about Governor Rendell's initiatives and to sign up for his weekly newsletter, visit http://www.governor.state.pa.us.

CONTACT:

Chuck Ardo

717-783-1116


'/>"/>
SOURCE Pennsylvania Office of the Governor
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Governor Rendell Offers adultBasic Coverage to 35,000 Uninsured Pennsylvanians
2. New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 8
3. Governor Rendell Announces $2.1 Million Investment in Small Transit Vehicles
4. Governor Rendell Proclaims Sept. 9-15 as Senior Community Center Week
5. Michigan Hospitals Receive Governors Award
6. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
7. Los Angeles Area Chamber of Commerce Endorses Governor Schwarzeneggers Health Care Proposal
8. Governor Rendell Announces CHIP Enrollment Clinics at Several Rite Aid Stores
9. $8,000 Winning Bids at Governors Livestock Auction to Benefit College-Bound Youth and Homeless
10. Blue Cross of California and the California Governors Council on Physical Fitness and Sports Launch Live Like a Champion Tour
11. AARP Calls on Governor Schwarzenegger to Discourage Veto of SCHIP Expansion Bill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)..., Results of St. Jude study could shape new treat...., Jan. 8 Scientists at...trated a more effective treatment for bacterial pn...ntibiotics clindamycin and azithromycin, which kil...are more effective than a standard first-line trea...
(Date:1/8/2009)...eview says it lowered bad cholesterol more effecti...althDay News) -- After nearly a year of review, U....ted the continued use of the controversial cholest... Drug Administration said there was no significant...tients taking Vytorin and patients taking the drug...
(Date:1/8/2009)..., BETHESDA, Md., Jan. 8 /PRNewswire-FirstCall/ -...pleased to announce that throughout the fourth qua..., Orthotics Center, Rocky Mountain Orthotic-Prosth...Services, Inc., First Coast Orthotics & Prosth.... These acquisitions add patient care centers to e...
(Date:1/8/2009)..., SAN FRANCISCO, Jan. 8 /PRNewswire-FirstCall...ounced that David Hung, M.D., president and chief,...l J.P. Morgan Healthcare,Conference on Wednesday,...tin,St. Francis Hotel in San Francisco. , ...d its clinical,development programs for Dimebon f...
Breaking Medicine News(10 mins):Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2
...management program cuts diabetes risk and is more ...s index (BMI) in overweight children. A family-b...chers at Yale School of Medicine was more successf...MI and insulin sensitivity than traditional clinic...
...rier cities like the Indian capital but also modif... warns a UN report released Wednesday. "Much of ...al areas from which they were first displaced," sa...lation 2007' report of the United Nations Populati...
...in Pakistan, evoking mixed reactions. <brThe...something extraordinary. Then the Lahore High Cou...comes as a pleasant surprise is the decision of th...e Court to release them on bail and hear their ap...
...ua, today welcomed Labors preventative health care... addressing Australias future health needs. Dr Ca...s ageing population and the increasing incidence o...including among younger people, will place great s...
Other Medicine News:Health News:Bright Bodies Weight Program Lowers Diabetes Risk, BMI in Obese Kids 2Health News:Same Sex Pair Get Relief in Pakistan 2Health News:Labor's Preventive Health Care Policy Looks to Address Future Needs 2
(Date:1/9/2009)...wire-FirstCall/ -- ProUroCare Medical Inc. (OTC Bu...of 3,050,000 units at $1.00 per unit, each unit co...emable warrant to purchase one share of common sto...mpany has granted the underwriter of the offering ...7,500 units to cover over-allotments, if any. The ...
(Date:1/9/2009)...re/ -- ESBATech AG, a leading developer of antibod...ation of the Phase I/IIa clinical development of i...eoarthritis (OA). This double-blind, randomized, p...signed to investigate the safety, tolerability and... intra-articular administration to patients with s...
(Date:1/8/2009)...wswire-FirstCall/ -- , - ThromboGenics, Lea...omacular Adhesion in the US and Europe , Th...nology company,focused on innovative treatments f...unces today that it has started the Phase III clin... treatment of back of the eye disease, the,final ...
(Date:1/8/2009)... second indication with clinical-stage, systemical...EMONT, Calif., Jan. 8 Quark Pharma...l company discovering and developing novel RNA int...ed that it has initiated patient dosing in its Pha... administered siRNA drug candidate QPI-1002 (previ...
Breaking Medicine Technology:ProUroCare Medical Inc. Announces Pricing of Equity Offering 2ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 2ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 3ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 4ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 2ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 3ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 4Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4Tips from the Journals of the American Society for Microbiology 107 1Tips from the Journals of the American Society for Microbiology 107 2Tips from the Journals of the American Society for Microbiology 107 3Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer 109 1Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer 109 2St Jude influenza survey uncovers key differences between bird flu and human flu 106 1St Jude influenza survey uncovers key differences between bird flu and human flu 106 2St Jude influenza survey uncovers key differences between bird flu and human flu 106 3Stanford study highlights cost effective method of lowering heart disease risks 104 1Stanford study highlights cost effective method of lowering heart disease risks 104 2Stanford study highlights cost effective method of lowering heart disease risks 104 3
...ent with ISIS 301012 produced at least 45% additio...ded to,maximally-tolerated lipid-lowering therapie...tCall/ -- Isis,Pharmaceuticals, Inc. announced upd...al of ISIS 301012 in patients with homozygous,fami...of which were,presented in March at the of Cardiol...
...from Phase III pivotal trial demonstrate safety an...rol fumarate for,patients with moderate to severe ...- Dey, L.P. announced,that two clinical data prese...ence of the American Thoracic Society (ATS) on,Sun...o. The,presentations will detail Phase III clinica...
Other Medicine Technology:Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 2Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 3Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 4
The PK Plasma-CISE™ (wire electrodes) and Plasma-CUT™ (coiled electrodes) are single use devices that produce precise, consistent tissue cutting with minimal thermal spread and Vapor seal
...gle use device that produces rapid, consistent, pr...nd vapor sealing of adjacent tissue for prostatic ...ccation. Often referred to as PlasmaKinetic vapori...the urologist the control needed to achieve the an...
Medium Surgical Clips. 6 clips per cartridge. Box of 30 cartridges with a total of 180 titanium clips per box. For secure vasal and other occlusion.
Sterile Disposable Thermal Cautery Tips for Vasectomy. Individually peel-pouched with dual plastic sheaths to cover non-sterile handle. Box of 10 tips.
Medicine Products: